title: The risks and costs of multiple-generic substitution of topiramate.
authors.forename: Nitin K
authors.initials: NK
authors.lastname: Sethi
authors.forename: Josh
authors.initials: J
authors.lastname: Torgovnick
authors.forename: Prahlad K
authors.initials: PK
authors.lastname: Sethi
authors.forename: Edward
authors.initials: E
authors.lastname: Arsura
authors.forename: Pierre
authors.initials: P
authors.lastname: Emmanuel Paradis
authors.forename: Mei S
authors.initials: MS
authors.lastname: Duh
authors.forename: Michael B
authors.initials: MB
authors.lastname: Durkin
authors.forename: George J
authors.initials: GJ
authors.lastname: Wan
mesh_terms: D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects; D016527:Drug Costs; D016568:Drugs, Generic / Q000008:administration & dosage* / Q000009:adverse effects*; D005632:Fructose / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D017048:Health Care Costs; D006801:Humans; D007348:Insurance, Health; D000077236:Topiramate
chemical_list: D000927:Anticonvulsants; D016568:Drugs, Generic; D000077236:Topiramate; D005632:Fructose